Literature DB >> 28425241

Incidence of cancer in the Turkish Republic of Northern Cyprus.

Ruqiya Pervaiz1, Pınar Tulay2, Faisal Faisal3, Nedime Serakinci4.   

Abstract

BACKGROUND/AIM: This study analyzed the incidence, trends, and common types of cancer in the Turkish Republic of Northern Cyprus (TRNC).
MATERIALS AND METHODS: This study is based on data collected from the office of the North Cyprus Cancer Registry, Ministry of Health, for 2007-2012. Data were arranged on the basis of age group, sex, and cancer site. Age standardized incidence rates (ASRs) were estimated with the world standard population. EVIEWS (version 9) software was used for statistical analysis.
RESULTS: Of 1395 registered cases, 52.33% (730) were reported in men and 47.67% (665) in women. The crude incidence rate was 96.41 in men and 101.74 in women. The average annual ASR was 88.88 in men and 87.76 in women with the cumulative rate of 21.47% and 14.69% in men and women, respectively. The most common cancers in men were skin (ASR 15.62), prostate (ASR 11.23), bladder (ASR 11.71), lung (ASR 8.01), and colorectal cancer (ASR 7.61), while in women these were breast (ASR 24.07), thyroid (ASR 14.93), skin (ASR 10.75), colorectal (ASR 6.05), and lymphoma (ASR 4.79). Linear regression analysis confirmed rising trends for both men's (10.79, P ≤ 0.03) and women's (14.67, P ≤ 0.04) cancers.
CONCLUSION: Our findings revealed an increasing trend of cancer incidence in the TRNC. For control and prevention, public awareness of the risk factors and proper screening programs should be recommended.

Entities:  

Mesh:

Year:  2017        PMID: 28425241     DOI: 10.3906/sag-1510-145

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  2 in total

1.  Overexpression of shugoshin1 predicts a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.

Authors:  Jiagui Mu; Li Fan; Duo Liu; Dongsheng Zhu
Journal:  Onco Targets Ther       Date:  2019-02-08       Impact factor: 4.147

2.  Thyroid Nodule Management: Thyroid-Stimulating Hormone, Ultrasound, and Cytological Classification System for Predicting Malignancy.

Authors:  Mohamed Abdulaziz Al Dawish; Asirvatham Alwin Robert; Mohammed A Thabet; Rim Braham
Journal:  Cancer Inform       Date:  2018-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.